AzTrials
AzTrials

Patellofemoral Joint DislocationNCT05375071

BFR After Biceps Tendon Repair and MPFLR

A study testing Blood Flow Restriction (BFR) Therapy and Physical Therapy in people with Patellofemoral Joint Dislocation and Bicep Tendon Rupture, run by Mayo Clinic at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The purpose of this study is to examine the effect of utilizing blood flow restriction (BFR) therapy after distal biceps tendon repair or medial patellofemoral ligament reconstruction (MPFLR) following a tear. Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
Blood Flow Restriction (BFR) Therapy and Physical Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
0 participants
Where
1 siteUnited States
Study dates
29 Jul 2025to 29 Jul 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Subjects will be recruited from our ambulatory sports medicine clinics. We will include patients aged 18-80 who suffered a biceps tear and are undergoing biceps repair or MPFLR

Who cannot join

  • Subjects will be excluded if they are undergoing revision biceps repair or revision MPFLR, history of DVT, neurovascular injury, unable to tolerate BFR treatment, unable to complete physical therapy, peripheral vascular disease
  • Subjects will be withdrawn from the study if they are unable to tolerate the BFR therapy. Additionally if they suffer from any complications of the therapy they will be withdrawn immediately. This will be facilitated by describing the reasons for withdrawal to the patient prior to initiating the study and ask patients and other providers to inform the investigators if there are any issues or concerns.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Mayo Clinic Rochester

    Rochester, Minnesota, 55902

Other trials in United States

About this study

Official title: Use of Blood Flow Restriction (BFR) Therapy in Peri-operative Rehabilitation Following Biceps Tendon Rupture and Medial Patellofemoral Ligament Reconstruction

The purpose of this study is to examine the effect of utilizing blood flow restriction (BFR) therapy after distal biceps tendon repair or medial patellofemoral ligament reconstruction (MPFLR) following a tear.

Being tested
Blood Flow Restriction (BFR) Therapy, Physical Therapy
Keywords
Bicep tendon repair, medial patellofemoral ligament reconstruction
Medical subject headings
Patellar Dislocation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Blood Flow Restriction (BFR) TherapyOther

    BFR Cuff will be applied to the most proximal portion of the affected arm or leg, immediately before performing exercises during physical therapy. The cuff will remain on for the entire time while an exercise is performed and will be removed in between exercises while the subject rests.

  • Physical TherapyOther

    Standard of care physical therapy consisting of a structured program progressing from range of motion to strength training and then functional tests

Study groups in NCT05375071
Study groupRoleWhat they receive
Conventional rehabilitation plus blood flow restriction (BFR) therapyExperimentalFollowing standard of care surgery, subjects will immediately be started in standard of care physical therapy. Additionally, a BFR Cuff will be applied during physical therapy.
Receives: Other: Blood Flow Restriction (BFR) Therapy
Conventional rehabilitationActive comparatorFollowing standard of care surgery, subjects will immediately be started in standard of care physical therapy.
Receives: Other: Physical Therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in strength

    Measured by a dynamometer

    Measured: Post-operative 6 weeks, 12 weeks, 16 weeks, and 6 months

Secondary outcomes (1)
  1. Change in range of motion

    Measured by a goniometer reported in degrees

    Measured: Post-operative 6 weeks, 12 weeks, 16 weeks, and 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 May 2022
  2. Study start29 Jul 2025
  3. Primary completion29 Jul 2025
  4. Study completion29 Jul 2025

Why it stopped: PI left Mayo Clinic, study never started

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05375071
Sponsor's protocol ID
21-006791
Status last verified
Sep 2025
First submitted
10 May 2022
Last updated
29 Sep 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Blood Flow Restriction (BFR) Therapy and Physical Therapy in people with Patellofemoral Joint Dislocation and Bicep Tendon Rupture, run by Mayo Clinic at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 29 Sep 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in strength (time frame: Post-operative 6 weeks, 12 weeks, 16 weeks, and 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in